All In Biotech

Drug Trial Radar · NCT07508124

Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants: a Pilot Study

Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants With a First Febrile Urinary Tract Infection: a Multi-center Pilot Study

Last checked: Nov 20, 2026Latest source record: Aug 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

May 8, 2026

Primary completion

Dec 2027

Study completion Dec 2027

Sponsor

Lead sponsor
Baylor College of MedicineAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Seattle Children's Hospital
First posted
Apr 2, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Male only, from 0 months, up to 5 months
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this smaller clinical trial is to evaluate the study design of this research to help prepare for a larger research study in the future. The future larger study would focus on whether steroid cream can reduce recurrent urinary tract infections in male infants, who are not circumcised. Male infants, who are enrolled in this study, would receive either the steroid cream or a placebo cream (a look alike cream without steroids). The cream would be applied twice a week for four weeks. Then there would be two follow up visits with the research team to measure whether the infant experienced any urinary tract infections and to measure parent perceptions of their experience participating in the study.

Conditions

  • Urinary Tract Infection

Interventions

  • betamethasone valerate 0.1% creamDrug

    Steroid cream applied to the foreskin and glans twice a day for four weeks.

  • Placebo creamDrug

    Placebo cream is applied to the foreskin and glans twice a day for four weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Feasibility of recruitment across different settingsTime frame: up to 2 weeks

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Texas Children's Hospital Main campus

    Houston, Texas · Recruiting

  • Texas Children's Hospital West Campus

    Katy, Texas · Not yet recruiting

  • Seattle Children's Hospital

    Seattle, Washington · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.